Brief: Viracta Therapeutics Reports Q2 Loss Of 28 Cents Per Share
09/08/2022 13:33
Aug 9 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
RECENT
UPDATES
* VIRACTA THERAPEUTICS INC - QTRLY LOSS PER SHARE OF $0.28
Source text for Eikon: ID:nPn2tyR9ra
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update